Anagenex
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
10 Roessler Rd Unit N, Woburn, Massachus...Phone Number
(978) 444-2649Website
www.anagenex.comRevenue
<$5 MillionIndustry
About Anagenex
Anagenex Org Chart
Is Anagenex your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Anagenex is spiking on competitors!
Check if Anagenex has recently received funding, and reach out quickly before it becomes old news!
Anagenex, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Anagenex recently announced quarterly report
Funding: Get notified immidiatlly once Anagenex has new funding data
Click to see if Anagenex had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Anagenex
Product Launch: Get notified when Anagenex launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Anagenex as Masked Content
Find 3 more new buyers
Compare Similar Companies to Anagenex
Compare insights from companies similar to Anagenex, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Anagenex is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Anagenex is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Anagenex.
Anagenex financials insights
Gather financial insights about Anagenex, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$30M
Anagenex Tech Stack
A closer look at the technologies used by Anagenex
Most Recent Scoops
Anagenex News & Media
C-Suite Shuffle: Sumitomo, Kineta, IDRx and More | BioSpace
This is the latest rundown of people coming and going from executive positions at biopharma companies that BioSpace covers. This regular column highlights the hired, fired, retired, promoted or resigning, as well as those personally named in lawsuits.Anagenex Expands Leadership Team with Appointment of Adrian Schreyer, Ph.D., as Chief Technology Officer
BOSTON--(BUSINESS WIRE)--Anagenex today announced the appointment of Adrian Schreyer, Ph.D., as Chief Technology Officer.Anagenex and Nimbus Announce a Multi-Target Collaboration to Discover Small Molecule Therapeutics for Multiple Indications
BOSTON--(BUSINESS WIRE)--Anagenex and Nimbus Announce a Multi-Target Collaboration to Discover Small Molecule Therapeutics for Multiple IndicationsAnagenex and Nimbus Announce a Multi-Target Collaboration to Discover Small Molecule Therapeutics for Multiple Indications
BOSTON--(BUSINESS WIRE)--Anagenex and Nimbus Therapeutics (Nimbus) today announced they have initiated a research collaboration. Anagenex, a pioneering drug discovery company pairing large-scale data generation with proprietary artificial intelligence (AI), will work closely with Nimbus to discover small molecule drugs for multiple challenging targets. Through this multi-target collaboration, the companies will apply Anagenex’s AI driven parallel biochemistry platform to generate billions of ex
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Anagenex
Anagenex is a pre-clinical biotechnology innovator advancing drug discovery through its small molecule directed evolution platform. The company's unique, machine learning-driven technology enables Anagenex to discover first-in-class and best-in-class small molecule medicines addressing historically intractable targets.... Read More